Evidence map›Paper›PMID 35023933›Full record

ArticleInfection and drug resistance2022

Two Phenotypes of

Hua Zou, Yan Shen, Chunli Li, Qiuhong Li

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Emergence ofVirulence · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Microbiology spectrum · 2024
    Article
  8. Article
  9. BioMed research international · 2023
    Article
  10. Article
  11. Emergence of a NDM-1-producing ST25Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hua Zou *Department of Laboratory Medicine, Chongqing Health Center for Women and Children, Chongqing, 400016, People's Republic of China.
Yan Shen *Department of Laboratory Medicine, Chongqing Health Center for Women and Children, Chongqing, 400016, People's Republic of China.
Chunli LiDepartment of Laboratory Medicine, Chongqing Health Center for Women and Children, Chongqing, 400016, People's Republic of China.
Qiuhong LiDepartment of Laboratory Medicine, Chongqing Health Center for Women and Children, Chongqing, 400016, People's Republic of China.
Chongqing Medical University · CNChildren's Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSevere infection has been the leading causes of neonatal death, especially the emergency of multidrug-resistant bacteria such as carbapenem-resistant Enterobacteriaceae. This study aimed to investigate the outbreak of carbapenem-resistant MATERIALS AND

methodsCR-KP were collected from neonatal ward of Chongqing Health Center for Women and Children between 2017 and 2019. Broth microdilution method was used to evaluate the antimicrobial activities in vitro, at the same time, the virulence of the strain was evaluated by in vitro and in vivo experiments. At last, prokaryotic chain specific transcriptome sequencing was conducted to explore the possible pathogenesis of CR-KP.

resultsIn this study, a total of 14 carbapenem-resistant-

conclusionOur findings revealed a new potential threat of NDM-1-positive CR-KP with higher virulence in neonatal ICU ward. We found two phenotypes of

Indexed as

carbapenem-resistant-Klebsiella pneumoniaeNDM-1neonatesvirulence

Identifiers

PMID35023933
PMCPMC8748007
OpenAlexW4206093431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.